Insider Transactions in Q4 2024 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 15
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
2,554
-5.6%
|
$140,470
$55.13 P/Share
|
|
Nov 13
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,666
-2.99%
|
$966,628
$58.97 P/Share
|
|
Nov 13
2024
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+5.6%
|
$66,664
$4.09 P/Share
|
|
Nov 06
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-11.62%
|
$360,000
$60.0 P/Share
|
|
Nov 06
2024
|
Jeff Cislini General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+10.41%
|
$216,000
$36.57 P/Share
|
|
Nov 04
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
87,500
+11.23%
|
$175,000
$2.29 P/Share
|
|
Nov 04
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
50,900
-14.5%
|
$2,799,500
$55.56 P/Share
|
|
Nov 01
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Indirect |
10,000
-19.67%
|
$550,000
$55.03 P/Share
|
|
Nov 01
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
9,100
-2.94%
|
$500,500
$55.02 P/Share
|
|
Nov 01
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
9,100
+2.86%
|
$36,400
$4.09 P/Share
|
|
Oct 31
2024
|
Sushil Patel |
SELL
Open market or private sale
|
Direct |
5,000
-20.04%
|
$270,000
$54.14 P/Share
|
|
Oct 31
2024
|
Sushil Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.7%
|
$120,000
$24.84 P/Share
|
|
Oct 14
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,666
-2.99%
|
$816,634
$49.73 P/Share
|
|
Oct 14
2024
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+5.6%
|
$66,664
$4.09 P/Share
|
|
Oct 11
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-11.62%
|
$300,000
$50.17 P/Share
|
|
Oct 11
2024
|
Jeff Cislini General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+10.41%
|
$216,000
$36.57 P/Share
|
|
Oct 11
2024
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-9.18%
|
$500,000
$50.3 P/Share
|
|
Oct 11
2024
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.41%
|
$20,000
$2.68 P/Share
|
|
Oct 11
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
30,000
-9.09%
|
$1,500,000
$50.36 P/Share
|
|
Oct 11
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+8.33%
|
$120,000
$4.09 P/Share
|
|
Oct 11
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-27.42%
|
$2,500,000
$50.34 P/Share
|
|
Oct 11
2024
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+11.5%
|
$200,000
$4.09 P/Share
|
|
Oct 08
2024
|
Barbara Weber |
SELL
Open market or private sale
|
Direct |
5,200
-28.47%
|
$249,600
$48.02 P/Share
|
|
Oct 01
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
10,000
-1.62%
|
$450,000
$45.13 P/Share
|
|
Oct 01
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.12%
|
$40,000
$4.09 P/Share
|